- Why Work With NSF?
NSF Pharma Biotech has helped companies that have been placed on import alert and have had their products subject to detention without physical examination (DWPE). We can determine what conditions are causing the import alert and assist your company with the remediation of these conditions. In addition, we can interface with the agency with your approval to help better understand the actions required to lift the import alert.
For more information about NSF Pharma Biotech regulatory enforcement action support in the U.S., email firstname.lastname@example.org or call +1 202.822.1850.
For more information about NSF Pharma Biotech regulatory enforcement action support in Europe, email email@example.com or call +44 1751 432 999.
Why Work With NSF?
Our team includes former U.S. FDA inspectors and experts who have a proven track record for addressing the most complex regulatory problems and compliance issues. We can interface with the agency on your behalf to help you to better understand the actions needed to lift the import ban.
When: September 27 - October 1, 2014 Where: Austin, TX Booth: 418 NSF Participation Elaine C. Messa, RAC, FRAPS, President,...
- 3 months ago
The long-awaited Qualified Persons template for declarations concerning Good Manufacturing Practice compliance of active substances and the accompanying guidance have...
- 4 months ago
On July 1, 2014, the Irish Medicines Board (IMB) will change its name to the Health Products Regulatory Authority (HPRA)....
- Monday, September 22, 2014
- 8:30am - 5:00pm
- York, United Kingdom
- Tuesday, September 23, 2014
- 8:30am - 5:00pm
- Manchester, UK, United Kingdom
- Tuesday, September 30, 2014
- 8:00am - 5:00pm
- Boston, Massachusetts, United States
- Thursday, October 2, 2014
- 10:00am - 11:00am
- NA, Massachusetts, United States